This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on march 16, 2018.(b)(4).The actual sample was not returned; however, a photo was provided which confirmed the observation.Documentation shows appropriate labeling was utilized for packaging before being sent out for sterilization, and released.The distribution center was notified for further investigation.It was determined that there was an order being processed at the same time for both of the part numbers and the two items being similar in appearance and the parts most likely got transposed during order processing.There was a failure in procedure execution as the picker did not pick the correct item and the packer nor shipper noted the error during their verification.The root cause was determined as the procedure was not followed as written.To prevent the future occurrences, the responsible associates will be retrained on the procedures.Also, the facility is improving the spacing of products that will allow better segregation for order processing.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|